Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Cancer Survival Analysis

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...

Treatment Resistant Cancers

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...

Treatment Resistent Cancers

Treatment Resistent Cancers

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Targeted Cancer Therapies

Targeted Cancer Therapies

Cancer Vaccines

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Physiotherapist and nurse perspectives on the acceptability and timing of patient-reported outcome measures in clinical practice: Balancing standardisation and flexibility.

Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation·2026

Same author

Factors associated with spontaneous vaginal birth in nulliparous women: A descriptive systematic review.

Women and birth : journal of the Australian College of Midwives·2023

Same author

Improved models of care for cancer survivors.

Lancet (London, England)·2022

Same author

Treatable but not curable cancer in England: a retrospective cohort study using cancer registry data and linked data sets.

BMJ open·2021

Same author

Building Personalized Cancer Follow-up Care Pathways in the United States: Lessons Learned From Implementation in England, Northern Ireland, and Australia.

American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting·2019

Same author

Implementing personalized pathways for cancer follow-up care in the United States: Proceedings from an American Cancer Society-American Society of Clinical Oncology summit.

CA: a cancer journal for clinicians·2019

Search research articles

Related Experiment Video

Updated: Mar 26, 2026

Therapy Testing in a Spheroid-based 3D Cell Culture Model for Head and Neck Squamous Cell Carcinoma

Therapy Testing in a Spheroid-based 3D Cell Culture Model for Head and Neck Squamous Cell Carcinoma

Published on: April 20, 2018

Addressing future challenges for cancer services: part II.

Jane Maher¹, Gina Radford²

¹Macmillan Cancer Support, 89 Albert Embankment, London, SE1 7UQ, UK.

Future Oncology (London, England)

|February 6, 2016

Summary

This discussion highlights the crucial collaboration between medical specialists and general practitioners in cancer care. It emphasizes the need for integrated approaches to improve patient outcomes and survivorship strategies.

Keywords:

Independent Cancer Taskforce cancer alliances cancer cost cancer registries cancer services cancer strategy for England community care multidisciplinary team public health

More Related Videos

Author Spotlight: Advancing Personalized Medicine in Ovarian Cancer

Author Spotlight: Advancing Personalized Medicine in Ovarian Cancer

Published on: February 23, 2024

Enhancing Chimeric Antigen Receptor-Extracellular Vesicles (CAR-EV) Technology: The Future of Cancer Therapy

Enhancing Chimeric Antigen Receptor-Extracellular Vesicles (CAR-EV) Technology: The Future of Cancer Therapy

Published on: September 19, 2025

Related Experiment Videos

Last Updated: Mar 26, 2026

Therapy Testing in a Spheroid-based 3D Cell Culture Model for Head and Neck Squamous Cell Carcinoma

Therapy Testing in a Spheroid-based 3D Cell Culture Model for Head and Neck Squamous Cell Carcinoma

Published on: April 20, 2018

Author Spotlight: Advancing Personalized Medicine in Ovarian Cancer

Author Spotlight: Advancing Personalized Medicine in Ovarian Cancer

Published on: February 23, 2024

Enhancing Chimeric Antigen Receptor-Extracellular Vesicles (CAR-EV) Technology: The Future of Cancer Therapy

Enhancing Chimeric Antigen Receptor-Extracellular Vesicles (CAR-EV) Technology: The Future of Cancer Therapy

Published on: September 19, 2025

Area of Science:

Oncology
Public Health
Healthcare Management

Background:

Jane Maher, Macmillan's Chief Medical Officer, has extensive experience in clinical oncology and developing nonsurgical oncology services.
Gina Radford, Deputy Chief Medical Officer for England, brings a strong background in public health and national project leadership.
The discussion reflects on the evolving landscape of cancer care, emphasizing the integration of specialist and generalist expertise.

Discussion:

The growing need for effective collaboration between specialists and general practitioners in cancer care is a key theme.
The importance of multidisciplinary teams in delivering comprehensive cancer services is underscored.
The role of leadership in driving improvements in cancer survivorship and patient support is explored.

Key Insights:

Maher's work on cancer survivorship initiatives and Radford's public health leadership demonstrate a commitment to improving patient journeys.
The development of Cancer Support and Information services, based on Maher's model, has been widely adopted.
The integration of clinical oncology and public health perspectives is vital for a holistic approach to cancer management.

Outlook:

Continued emphasis on collaborative models between specialists and generalists will enhance cancer care delivery.
Further development of survivorship programs and support services is essential for improving long-term patient well-being.
The insights from experienced leaders like Maher and Radford offer valuable guidance for future healthcare strategies in oncology and public health.